AppliedVR’s EaseVRx scores FDA De Novo clearance for treating chronic lower back pain

AppliedVR’s EaseVRx scores FDA De Novo clearance for treating chronic lower back pain

The news comes about a week after AppliedVR announced it raised $36 million in Series B funding.

Vote:
0